We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
+$617M
(+40%)
Cap. Flow
+$399M
Cap. Flow
% of AUM
18.35%
Top 10 Holdings %
Top 10 Hldgs %
22.83%
Holding
3,224
New
565
Increased
1,310
Reduced
679
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXON
Axon Enterprise
AXON
|
+$52.4M |
| 2 |
Panagram BBB-B CLO ETF
CLOZ
|
+$37.6M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.3M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$24.4M |
| 5 |
Merck
MRK
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.9M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$20.7M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$19.4M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.2M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.5% |
| 2 | Financials | 4.24% |
| 3 | Healthcare | 3.21% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.75B
| $43.6K | ﹤0.01% |
+1,224
| New | +$41.6K |
|
1302
Prosperity Bancshares
PB
$8.88B
| $43.6K | ﹤0.01% |
621
+563
| +971% | +$38.8K |
|
1303
Viatris
VTRS
$19B
| $43.5K | ﹤0.01% |
4,866
+2,284
| +88% | +$19.3K |
|
1304
Boot Barn
BOOT
$4.97B
| $43.3K | ﹤0.01% |
86
+35
| +69% | +$4.64K |
|
1305
Artesian Resources
ARTNA
$355M
| $43.3K | ﹤0.01% |
1,290
| – | – |
|
1306
Solventum
SOLV
$14.1B
| $43.2K | ﹤0.01% |
570
+115
| +25% | +$8.14K |
|
1307
Atlas Energy Solutions
AESI
$1.38B
| $43.2K | ﹤0.01% |
3,229
+1,540
| +91% | +$21K |
|
1308
C.H. Robinson
CHRW
$17.1B
| $43.1K | ﹤0.01% |
449
+364
| +428% | +$34.1K |
|
1309
WisdomTree
WT
$3.25B
| $43.1K | ﹤0.01% |
3,743
+3,669
| +4,958% | +$34.4K |
|
1310
Timken Company
TKR
$8.92B
| $43K | ﹤0.01% |
344
+212
| +161% | +$14.4K |
|
1311
Fidelity MSCI Financials Index ETF
FNCL
$2.41B
| $43K | ﹤0.01% |
56
| – | – |
|
1312
iShares MSCI ACWI ETF
ACWI
$33.3B
| $42.9K | ﹤0.01% |
+334
| New | +$40K |
|
1313
Everest Group
EG
$14.2B
| $42.8K | ﹤0.01% |
126
+1
| +0.8% | +$345 |
|
1314
First Trust Indxx Medical Devices ETF
MDEV
$3.08M
| $42.8K | ﹤0.01% |
2,082
| – | – |
|
|
SW
1315
Smurfit Westrock
SW
$24.6B
| $42.8K | ﹤0.01% |
991
+470
| +90% | +$20.1K |
|
1316
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $42.8K | ﹤0.01% |
359
+126
| +54% | +$14.9K |
|
1317
Regeneron Pharmaceuticals
REGN
$79.5B
| $42.5K | ﹤0.01% |
81
+19
| +31% | +$10.6K |
|
1318
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $42.5K | ﹤0.01% |
534
+5
| +0.9% | +$394 |
|
1319
Kilroy Realty
KRC
$4.34B
| $42.4K | ﹤0.01% |
1,237
+51
| +4% | +$1.66K |
|
1320
Resideo Technologies
REZI
$3.95B
| $42.4K | ﹤0.01% |
1,923
+199
| +12% | +$3.8K |
|
1321
Kelly Services Class A
KELYA
$542M
| $42.3K | ﹤0.01% |
471
+341
| +262% | +$4.02K |
|
|
IMOS
1322
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $42.1K | ﹤0.01% |
+2,326
| New | +$41.2K |
|
1323
Cousins Properties
CUZ
$4.91B
| $42.1K | ﹤0.01% |
1,401
-247
| -15% | -$6.97K |
|
1324
Brown-Forman Class B
BF.B
$13B
| $42K | ﹤0.01% |
1,545
-1,139
| -42% | -$36.6K |
|
1325
Jones Lang LaSalle
JLL
$16.7B
| $41.9K | ﹤0.01% |
164
-21
| -11% | -$4.81K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Arax Advisory Partners held 3,224 positions worth $2.18B, up 40% from $1.56B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Arax Advisory Partners deployed $399M of net new capital in Q2 2025, opening 565 new positions and adding to 1,310 existing holdings. Its largest new stake was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $21.9M trimmed.
- Arax Advisory Partners's largest Q2 2025 buy was Panagram BBB-B CLO ETF: 1,423,147 shares worth $38.1M.
- Arax Advisory Partners added most to Axon Enterprise in Q2 2025, an estimated $52.4M increase.
- Arax Advisory Partners's biggest Q2 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $21.9M.
- Arax Advisory Partners fully exited YieldMax MSTR Option Income Strategy ETF in Q2 2025, selling an estimated $102K.
- Arax Advisory Partners's ten largest holdings make up 23% of its $2.18B portfolio in Q2 2025.
- Arax Advisory Partners opened 565 new positions and closed 193 in Q2 2025.
- Arax Advisory Partners's portfolio value rose 40% quarter-over-quarter to $2.18B.
Based on Arax Advisory Partners's 13F filing for Q2 2025, filed 12 Aug 2025.